Arcosa IncACA

Why is Arcosa (ACA) moving?

Q3 202621 Jun – 7 Aug 2026

▲2▼1

CRH agrees to acquire Arcosa for $8.5 billion CRH will buy Arcosa for $150 per share in cash, a 10% premium to the prior close. This puts a firm floor under the stock near the deal price and is the main reason ACA is moving. The deal is expected to close in early 2027.
This is the central event that now determines ACA's price, as the stock will trade around the buyout price.
Arcosa misses Q2 estimates and suspends guidance Arcosa reported weaker-than-expected second-quarter results and stopped giving financial forecasts because of the pending merger. While this shows the business is slowing, the buyout price is already agreed, so the miss has little impact on the deal value.
It is the main counterweight to the positive deal news, but its effect on the stock is limited by the fixed buyout price.
CRH's strong Q2 and strategic fit support deal completion CRH reported solid second-quarter results and reaffirmed its full-year outlook, showing it has the financial strength to complete the acquisition. The deal adds aggregates and energy infrastructure assets that fit CRH's growth strategy, making it more likely to close.
It reduces the risk that the buyer walks away, which helps keep ACA's stock near the deal price.

July 202621 Jun – 7 Aug 2026

▲2▼1

CRH agrees to acquire Arcosa for $8.5 billion CRH will buy Arcosa for $150 per share in cash, a 10% premium to the prior close. This puts a firm floor under the stock near the deal price and is the main reason ACA is moving. The deal is expected to close in early 2027.
This is the central event that now determines ACA's price, as the stock will trade around the buyout price.
Arcosa misses Q2 estimates and suspends guidance Arcosa reported weaker-than-expected second-quarter results and stopped giving financial forecasts because of the pending merger. While this shows the business is slowing, the buyout price is already agreed, so the miss has little impact on the deal value.
It is the main counterweight to the positive deal news, but its effect on the stock is limited by the fixed buyout price.
CRH's strong Q2 and strategic fit support deal completion CRH reported solid second-quarter results and reaffirmed its full-year outlook, showing it has the financial strength to complete the acquisition. The deal adds aggregates and energy infrastructure assets that fit CRH's growth strategy, making it more likely to close.
It reduces the risk that the buyer walks away, which helps keep ACA's stock near the deal price.

Latest21 Jun – 7 Aug 2026

▲2▼1

CRH agrees to acquire Arcosa for $8.5 billion CRH will buy Arcosa for $150 per share in cash, a 10% premium to the prior close. This puts a firm floor under the stock near the deal price and is the main reason ACA is moving. The deal is expected to close in early 2027.
This is the central event that now determines ACA's price, as the stock will trade around the buyout price.
Arcosa misses Q2 estimates and suspends guidance Arcosa reported weaker-than-expected second-quarter results and stopped giving financial forecasts because of the pending merger. While this shows the business is slowing, the buyout price is already agreed, so the miss has little impact on the deal value.
It is the main counterweight to the positive deal news, but its effect on the stock is limited by the fixed buyout price.
CRH's strong Q2 and strategic fit support deal completion CRH reported solid second-quarter results and reaffirmed its full-year outlook, showing it has the financial strength to complete the acquisition. The deal adds aggregates and energy infrastructure assets that fit CRH's growth strategy, making it more likely to close.
It reduces the risk that the buyer walks away, which helps keep ACA's stock near the deal price.